<code id='12E1CAA55B'></code><style id='12E1CAA55B'></style>
    • <acronym id='12E1CAA55B'></acronym>
      <center id='12E1CAA55B'><center id='12E1CAA55B'><tfoot id='12E1CAA55B'></tfoot></center><abbr id='12E1CAA55B'><dir id='12E1CAA55B'><tfoot id='12E1CAA55B'></tfoot><noframes id='12E1CAA55B'>

    • <optgroup id='12E1CAA55B'><strike id='12E1CAA55B'><sup id='12E1CAA55B'></sup></strike><code id='12E1CAA55B'></code></optgroup>
        1. <b id='12E1CAA55B'><label id='12E1CAA55B'><select id='12E1CAA55B'><dt id='12E1CAA55B'><span id='12E1CAA55B'></span></dt></select></label></b><u id='12E1CAA55B'></u>
          <i id='12E1CAA55B'><strike id='12E1CAA55B'><tt id='12E1CAA55B'><pre id='12E1CAA55B'></pre></tt></strike></i>

          
          WSS
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          hotspot